Figure 5 | Scientific Reports

Figure 5

From: Mitochondria-targeted esculetin alleviates mitochondrial dysfunction by AMPK-mediated nitric oxide and SIRT3 regulation in endothelial cells: potential implications in atherosclerosis

Figure 5

Mito-Esc pretreatment rescues oxidant-induced deregulation of mitochondrial biogenesis.

(a) HAEC were pretreated with Mito-Esc (2.5 μM) for 2 h prior to the addition of H2O2 (0.5 mM) for 8 h and mitochondria genome-encoded gene expressions as indicated were measured by qRT-PCR. (b) HAEC were treated with various concentrations of H2O2 (0.25–0.75 mM) for 8 h and PGC-1α, SIRT3 and TFAM mRNA levels were measured by RT-PCR. (c) Same as b except that, protein levels were measured by Western blot analysis. (d) Same as c except that cells were incubated with H2O2 (0.5 mM) for various time points (2–8 h). (e) Same as d except that, cells were treated with different concentrations of Mito-Esc (1–5 μM) for 8 h. (f,g) HAEC were pretreated with Mito-Esc for 2 h prior to the addition of H2O2 (0.5 mM) for 8 h and PGC-1α, SIRT3 and TFAM mRNA (f) and protein (g) levels were measured by RT-PCR and Western blot analysis respectively. *Significantly different (p < 0.05) compared to untreated conditions. #Significantly different (p < 0.05) compared H2O2 treated condition. Results indicated are average of three independent experiments.

Back to article page